Nutrigenomics Institute

20/04/2026

New Alzheimer’s drugs under the microscope: promising advances, questioned benefits.🧐

For years, the most recent Alzheimer’s treatments have been touted as a potential turning point in the fight against this neurodegenerative disease.
However, a wide-ranging scientific review is calling into question the extent to which these drugs offer real improvements in patients’ lives.
More information in this link and in the section NEWS of our website 🤓
https://nutrigenomicsinstitute.com/nutrigenomics-news/new-alzheimers-drugs-under-the-microscope-promising-advances-questioned-benefits/

13/04/2026

Colorectal Cancer Evolves: New Strategies That Reduce the Need for Surgery 🧐

Colorectal cancer has become one of the main health problems in Spain. Far from what is usually thought, it is not breast or prostate cancer that is the most frequent, but this type of digestive tumor.

This high number of cases has driven a transformation in their treatment, which is no longer based exclusively on surgery, as was traditionally the case.🤓
More info in this linbk and in the sectioin NEWS of our website 🤓

https://nutrigenomicsinstitute.com/nutrigenomics-news/colorectal-cancer-evolves-new-strategies-that-reduce-the-need-for-surgery/

07/04/2026

One step closer to understanding the origin of cancer: the hidden role of “mobile” DNA🧐

Cancer research has entered a new phase in which not only point mutations in genes are studied, but also more complex mechanisms that affect the overall functioning of the genome. In this context, a recent study led by Spanish researchers has opened up a promising way to better understand the origin of some tumours.

These scientists have discovered that certain mobile fragments of DNA – genetic elements capable of moving within the genome – can play a key role in the appearance and evolution of cancer.
MORE INFORMATION IN THIS LINK AND IN THE SECTION NEWS OF OUR WEBSITE 🤓
https://nutrigenomicsinstitute.com/nutrigenomics-news/one-step-closer-to-understanding-the-origin-of-cancer-the-hidden-role-of-mobile-dna/

30/03/2026

The detection of tumor DNA in blood: a paradigm shift in breast cancer🧐

Oncology is undergoing a silent but profound transformation: the possibility of detecting cancer relapses before they are even visible in traditional clinical trials. One of the most promising advances in this field is the analysis of circulating tumor DNA (ctDNA), a tool that could anticipate the recurrence of breast cancer and radically change the way the disease is treated.
More information in this link and in the section NEWS of our website 🤓
https://nutrigenomicsinstitute.com/nutrigenomics-news/the-detection-of-tumor-dna-in-blood-a-paradigm-shift-in-breast-cancer/

16/03/2026

The genetics of the skin: how our genes determine its structure, aging, and pigmentation 🧐
The skin is the largest organ in the human body and one of the most genetically complex. Its appearance, regenerative capacity, resistance to sun damage, hydration, and rate of aging are influenced by multiple genes that regulate biological processes such as collagen production, pigmentation, antioxidant response, and inflammation.
More information in this link and in the section NEWS of our website 🤓
https://nutrigenomicsinstitute.com/nutrigenomics-news/the-genetics-of-the-skin-how-our-genes-determine-its-structure-aging-and-pigmentation/

09/03/2026

In recent years, medications like Ozempic (semaglutide) have become key players in the treatment of obesity and overweight. Their effectiveness in reducing appetite and facilitating weight loss has generated enthusiasm both in the medical field and on social media.   However, one key question is ge...

09/03/2026

Ozempic and weight rebound: what science really says when treatment is stopped🧐
In recent years, medications like Ozempic (semaglutide) have become key players in the treatment of obesity and overweight. Their effectiveness in reducing appetite and facilitating weight loss has generated enthusiasm both in the medical field and on social media.
However, one key question is generating increasing debate: what happens when treatment is stopped?

More information in this link and in the section NEWS of our website 🤓

In recent years, medications like Ozempic (semaglutide) have become key players in the treatment of obesity and overweight. Their effectiveness in reducing appetite and facilitating weight loss has generated enthusiasm both in the medical field and on social media.   However, one key question is ge...

02/03/2026

The New Era of Nutritional Treatment: Merging Genetic and Microbiota Data 🧐

In the latest advance in nutritional science, traditional approaches based on generalized dietary recommendations are giving way to much more personalized strategies. The central idea revolutionizing this field is the fusion of genetic testing data with gut microbiota profiles to design personalized nutritional treatments that maximize health and reduce the risk of chronic diseases
More info in this link and in teh section NEWS of our website 🤓
https://nutrigenomicsinstitute.com/nutrigenomics-news/the-new-era-of-nutritional-treatment-merging-genetic-and-microbiota-data/

23/02/2026

Barbacid’s research in Spain and the advance against pancreatic cancer
The challenge of financing the next phase. 🧐

Although the preclinical progress is remarkable, moving towards human trials requires considerable funding . Barbacid and his team have estimated that they could need around 30 million euros to advance to clinical trials and regulatory studies.

More information in this link and in the section NEWS of our website 🤓
https://nutrigenomicsinstitute.com/nutrigenomics-news/barbacids-research-and-the-advance-against-pancreatic-cancer/